RecruitingPhase 2NCT07065240
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Sponsor: Seaport Therapeutics
Boston, MA · Russells Mills, MA · +26 more sites